InvestorsHub Logo
Followers 19
Posts 904
Boards Moderated 0
Alias Born 11/28/2016

Re: None

Tuesday, 06/30/2020 3:04:12 PM

Tuesday, June 30, 2020 3:04:12 PM

Post# of 26809
Just found this company (bought 300K shares) with these highlights:

"Our coating is a biodegradable, resorbable and hemocompatible surface substrate coating for metal stents to provide embolic protection in stenting procedures. We believe our coating for stents has increased potential over and above what is on the market now to block restenosis (recurrence of narrowing). It is not cytotoxic, and it fights inflammation, which we believe is the key cause of restenosis such that implanting a stent with our coating may be superior in preventing restenosis."

"In addition, the Atherectomy Catheter II includes a vacuum mechanism that extracts any removed plaque from the arteries and from the patient."

" ... resulting in $68,000.00 of the principal amount of the Debt being retired and reducing AngioSoma's annual interest expense by approximately $8,160.00 because of conversion of Debt.

"The successful conversion of Debt to equity has strengthened our balance sheet and effectively left AngioSoma with substantially less long-term debt payable," said Alex Blankenship, CEO of AngioSoma. "The additional funding available from conversion of Debt further improves our balance sheet as we continue to execute the roll-out of our Muscles4U workout enhancement products later this year."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GSTC News